跳至主要内容
临床试验/ACTRN12612000751875
ACTRN12612000751875已完成未知

Compare the effect of surgery therapy versus radiotherapy Combined with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with portal vein invasion

Eastern Hepatobiliary Surgery Hospital0 个研究点目标入组 360 人开始时间: 2012年7月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. resectable HCC with PVTT; 2. there was no previous treatment; 3.there were no other malignancies; 4. compensated cirrhosis with Child-Pugh class A, or B; 5. there were no tumor invasion of hepatic vein, bile duct,inferior vena cava; 6.there was no extrahepatic metastasis; 7.patients had no serious associated medical diseases;8. Understanding and being willing to sign the informed consent form

排除标准

  • 1.cannot be follow-up 2.severe liver, renal, or brain dysfunction; 3. with tumor thrombi in the hepatic vein 4.with extrahepatic metastasis

研究者

相似试验